Earlier this month, peer-reviewed medical journal The Lancet published an interim analysis from the Phase III trial of the Russian Sputnik V vaccine, showing its 91.6 percent efficacy against symptomatic COVID-19.
Honduras has registered Russia’s Sputnik V COVID vaccine, the Russian Direct Investment Fund (RDIF) said.
A corresponding announcement was made on the vaccine’s Twitter account.
Developed by the Gamaleya Epidemiology and Microbiology Centre and registered by the Russian Health Ministry on 11 August 2020, Sputnik V became the world’s first vaccine against COVID-19.
Since then, it has been approved by more than 30 countries, including Belarus, Argentina, Bolivia, Serbia, Algeria, Palestine, Venezuela, Paraguay, Turkmenistan, Hungary, the UAE, Iran, Republic of Guinea, Tunisia, Armenia, Mexico, Nicaragua, Bosnia and Herzegovina’s Republika Srpska, Lebanon, Myanmar, Pakistan, Mongolia, Bahrain, Montenegro, Saint Vincent and the Grenadines, Kazakhstan, Uzbekistan, Gabon, San Marino, Ghana and Kyrgyzstan.
Sourse: sputniknews.com
